CLINICAL_TRIALS
trial_result
· 2012-07-04
Clinical Trial Update: Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome [Phase 2]
Summary
Phase 2 pilot trial evaluating an mTOR inhibitor for Peutz-Jeghers syndrome was terminated, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Utah | Conditions: Peutz-Jeghers Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2012-07-04